Source: International Congress 2017 – Current challenges in COPD evaluation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Fähndrich (Homburg/Saar, Germany). Exacerbations and duration of smoking abstinence are associated with the annual decline in lung function in individuals with PiZZ alpha-1-antitrypsin deficiency. 403

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD Source: Eur Respir J 2011; 37: 32-38 Year: 2011 Predictors of accelerated decline in lung function in adult-onset asthma Source: Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017 Year: 2018 COPD non-exacerbator phenotype is associated with current smoking but not with Haptoglobin phenotype Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma Source: Eur Respir J, 54 (3) 1801580; 10.1183/13993003.01580-2018 Year: 2019 Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations Source: Eur Respir J 2007; 30: Suppl. 51, 169s Year: 2007 ADAM33 SNPs are associated with excess FEV1 decline in severe early onset COPD Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017 Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Daily physical activity and lung function decline in adult-onset asthma Source: International Congress 2017 – Respiratory and exercise physiology Year: 2017 Does smoking affect  nutritional status and renal function in patients with COPD? Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Accelerated decline in lung function in adults with a history of remitted childhood asthma Source: Eur Respir J, 59 (1) 2100305; 10.1183/13993003.00305-2021 Year: 2022 Survival of patients with severe chronic obstructive pulmonary disease in relation to smoking habits Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Is obstructive lung disease correlated to age and smoking habit or is there more? Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016